🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE
Organization EASTERN VIRGINIA MEDICAL SCHOOLLocation NORFOLK, UNITED STATESPosted 1 Aug 2025Deadline 28 Feb 2026 ⚠️
NIHUS FederalResearch GrantFY2025Active Follow-upAddressAdherenceAge YearsClinic VisitsClinicalClinical EvaluationClinical InvestigatorClinical Practice GuidelineClinical ResearchClinical StudyClinical TestingClinical TrialsClinical Trials NetworkCollaborationsConduct Clinical TrialsContraceptionContraceptive AgentsContraceptive methodsContraceptivesContracting OpportunitiesContractorContractsCorlutinaCorluviteCyclogestD-NorgestrelDataData CollectionDepo-Medroxyprogesterone AcetateDevelopmentDevicesDocumentationDoseDrug PrecursorsDrugsEnrollmentEnsureEquipmentEstrogensEvaluationFamilyFecundabilityFecundityFeedbackFertilityFertility ControlFormulationFosteringFundingGCP standardGestagenic AgentsGestagensGestationGestironGestoneGoalsGood Clinical PracticeGovernmentGovernment AgenciesHigh Risk WomanHuman ResourcesHydrolysisImplantIncidenceIndividualInfrastructure ActivitiesInhibition of FertilizationInjectableInjectionsInternationalIntramuscular InjectionsLeadLevonorgestrelLipo-LutinLuteohormoneLutocyclinLutocylin MLutogylLutromoneManpowerMedicationMedroxyprogesterone 17-AcetateMedroxyprogesterone AcetateMedroxyprogesteroni AcetasMensesMenstruationMethodsMethylacetoxyprogesteroneMetipregnoneModificationMonitorMoodsNICHDNational Institute of Child Health and Human DevelopmentObesityOral ContraceptivesOutcomeOvulationOvulation InhibitionOvulation SuppressionParticipantPb elementPerformancePharmaceutical PreparationsPhasePhase III studyPregnancyPreparationPreparednessPrivate SectorPrivatizationPro-DrugsProceduresProdrugsProgestagenic AgentsProgestasertProgestational AgentsProgestational CompoundsProgestational HormonesProgesterone AgentsProgestinsProgestogelProgestogensProgestolProgestonProgram DevelopmentProlidonProlutonProtocolProtocols documentationPublic HealthQualifyingReadinessRecommendationRecordsRecoveryRegulationRegulatory approvalReportingReproductive HealthResearchResolutionRiskRisk FactorsSafetyScienceSelf AdministeredSelf AdministrationSeriesServicesSiteStructureSubcutaneous InjectionsSummary ReportsSyngesteroneTarget PopulationsTechnology TransferTherapeutic EstrogenTherapeutic ProgestinTimeTraining ActivityTranslatingUtrogestanVisitWeight GainWeight IncreaseWomanWorkactive followupactive methodactive techniqueactive treatmentadiposityat-risk femalesat-risk womenbasebasesbirth control pillbody weight gainbody weight increaseclinical developmentclinical practice and guidelinesclinical research siteclinical siteclinical testcommercializationconferencecontraceptive efficacyconventioncorpulencedesigndesigningdevelopment policydevelopmentaldrug candidatedrug/agentenrollexperiencefemales at high riskfirst in manfirst-in-humanfollow upfollow-upfollowed upfollowupheavy metal Pbheavy metal leadhigh risk femaleshormonal contraceptionhormonal contraceptiveimprovedinnovateinnovationinnovativeinterestintramuscular drug administrationl-Norgestrelmenmenstrual periodmonthly periodmonthly periodsnext generationnovelopen labelopen label studyparticipant enrollmentpatient enrollmentpersonnelphase 3 studypopulation healthpreparationspublic-private partnershiprecruitregulatory authorizationregulatory certificationregulatory clearanceresearch clinical testingresolutionssafety assessmentscreeningscreeningsside effectsubcutaneoussubdermalsubdermal injectionsummitsymposiasymposiumthrombotictraining moduletraining opportunityvenous thromboembolismwomen at high riskwt gain
Applications closed.
Description preview
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) serves as the lead federal agency advancing research in fertility optimization. Within NICHD, the Contraceptive Development Program (CDP) under the Division of Population Health Research (DiPHR) is tasked with developing novel contraceptive methods for both…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click